The immune system is a complex and adaptive learning system which has evolved to defend the individual. It has multiple levels (molecular, cellular, organ and tissue, organism, and organism-toorganism) and is also combinatorial in nature with a large number of products.
Immune intervention, such as vaccination, is the most effective method for the control of disease and the greatest achievements include eradication of smallpox, near-elimination of polio, and savings of some 170 million person-years. Vaccination has been used in the control of over two dozen diseases by the 50 or so successful vaccines which have been developed to date.
Large-scale studies of the immune system, also known as immunomics, is the key factor driving the current wave in vaccine development. The main objectives of ImmunoGrid are to:
For further information, please visit:
Project co-ordinator:
The Interuniversity Consortium of Northeastern Italy for Automated Computing (CINECA) (IT)
Partners:
Timetable: from 02/06 to 01/09
Total cost: 2.622.274
EC funding: 1,951,042
Instrument: STREP
Project Identifier: IST-2004-028069
Microsoft in Healthcare and Life Sciences
Company Profiles:
Agfa HealthCare |
Carestream Health |
Cetrea |
CompuGroup Medical |
CSC |
CSW Group Ltd |
dbMotion |
Dell Healthcare and Life Sciences |
EMIS |
empirica |
First DataBank |
GE Healthcare |
IBM Healthcare |
Initiate Systems |
InterComponentWare AG (ICW) |
Intel in Healthcare |
InterSystems Corporation |
iPLATO Healthcare |
iSOFT |
Map of Medicine |
Oracle Healthcare Solutions |
Orion Health |
Philips Healthcare |
Picis |
SAP for Healthcare |
Siemens Healthcare |
System C Healthcare |
Telehealth Solutions |
Tieto |
Transinsight |
Toumaz |
Tunstall | ...